Share this post on:

Product Name :
PF-06409577

Search keywords :
PF-06409577

drugId :
null

Target Vo:
Protein kinase AMP-activated non-catalytic subunit beta 1

Target Vo Short Name :
PRKAB1

Moa_Name:
Protein kinase AMP-activated non-catalytic subunit beta 1 activators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Thioredoxin Rabbit mAb Autophagy
Elotuzumab Technical Information
Caspase-8 Antibody: Caspase-8 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 55 kDa, targeting to Caspase-8. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related